Oligometastatic colorectal cancer (CRC) is a clinically relevant entity, and surgery is the gold standard therapeutic option. Current guidelines recommend evaluating other local ablative treatments (LATs) in patients not eligible for surgery. Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) and stereotactic body radiation therapy (SBRT) are emerging as highly beneficial less-invasive LATs in alternative to surgery. In our paper, we report the first case in literature of lymph node metastases from CRC treated sequentially with EUS-RFA and SBRT, providing evidence of their efficacy and safety. LATs combined with systemic chemotherapy might be included in a multimodal therapeutic approach to oligometastatic disease.
Borrelli De Andreis, F., Calegari, M. A., Romano, A., Brizi, M. G., Sofo, L., Boskoski, I., Costamagna, G., Attili, F., Combination of endoscopic ultrasound-guided radiofrequency ablation and adaptive radiation therapy for the treatment of lymph node metastases from colon adenocarcinoma: A case report, <<CURRENT PROBLEMS IN CANCER. CASE REPORTS>>, 2023; 9 (march): N/A-N/A. [doi:10.1016/j.cpccr.2023.100216] [https://hdl.handle.net/10807/265334]
Combination of endoscopic ultrasound-guided radiofrequency ablation and adaptive radiation therapy for the treatment of lymph node metastases from colon adenocarcinoma: A case report
Borrelli De Andreis, Federica;Calegari, Maria Alessandra;Romano, Angela;Brizi, Maria Gabriella;Sofo, Luigi;Boskoski, Ivo;Costamagna, Guido;Attili, Fabia
2023
Abstract
Oligometastatic colorectal cancer (CRC) is a clinically relevant entity, and surgery is the gold standard therapeutic option. Current guidelines recommend evaluating other local ablative treatments (LATs) in patients not eligible for surgery. Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) and stereotactic body radiation therapy (SBRT) are emerging as highly beneficial less-invasive LATs in alternative to surgery. In our paper, we report the first case in literature of lymph node metastases from CRC treated sequentially with EUS-RFA and SBRT, providing evidence of their efficacy and safety. LATs combined with systemic chemotherapy might be included in a multimodal therapeutic approach to oligometastatic disease.File | Dimensione | Formato | |
---|---|---|---|
combination.pdf
accesso aperto
Licenza:
Creative commons
Dimensione
2.84 MB
Formato
Adobe PDF
|
2.84 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.